Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>Updated 10th June: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announced that its proposed IPO onto the Main Market, which was expected to occur in late June, will be delayed.</li>
<li>A routine thematic compliance inspection commenced earlier this year in the BVI, which was disclosed in the Company's Registration Document, requires additional time to enable finalisation ahead of the IPO.</li>
<li>The inspection process is close to completion and the Company anticipates only a short delay to the IPO timetable. </li>
</ul>


Updated 10th June: iFOREX Financial Trading, the fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, announced that its proposed IPO onto the Main Market, which was expected to occur in late June, will be delayed.
A routine thematic compliance inspection commenced earlier this year in the BVI, which was disclosed in the Company's Registration Document, requires additional time to enable finalisation ahead of the IPO.
The inspection process is close to completion and the Company anticipates only a short delay to the IPO timetable. 


Quartix Holdings plc - Hybridan Small Cap Feast: 03/07/2025

<ul>
<li>Further to the announcement on 24 February 2025, the mining royalty and streaming company announced that the long stop date of 18 April 2025 to acquire a near-producing gold mining royalty has now passed.</li>
<li>Therefore, the Company is no longer moving forward with the Proposed Acquisition.</li>
<li>However, the Company is progressing other opportunities in its pipeline of activities. </li>
</ul>


Further to the announcement on 24 February 2025, the mining royalty and streaming company announced that the long stop date of 18 April 2025 to acquire a near-producing gold mining royalty has now passed.
Therefore, the Company is no longer moving forward with the Proposed Acquisition.
However, the Company is progressing other opportunities in its pipeline of activities. 


<ul>
<li>The specialist in currency risk management and alternative banking, reports finals to December 2024.</li>
<li>Its revenue is £50.3m up from £49.9m, with growth in the number of clients offset by a reduction in average spend.</li>
<li>The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m. </li>
</ul>


The specialist in currency risk management and alternative banking, reports finals to December 2024.
Its revenue is £50.3m up from £49.9m, with growth in the number of clients offset by a reduction in average spend.
The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m. 


Surface Transforms PLC - Duplicate of Hybridan Small Cap Feast: 02/04/2025

<ul>
<li>Aptamer Group 0.33p £6.57m (APTA.L) The developer of novel Optimer binders to enable innovation in the life sciences industry yesterday reported Interims to December 2024.</li>
<li>Its revenue improved to £0.7m from £0.3m with an EBITDA loss of £1.1m down from £1.8m, while net cash is £2m after raising funds last year at 0.2p.</li>
<li>The strategy is to create value through the development of high-value Optimer assets with licensing potential through commercial partners, while generating revenues from fee-for-service work, which has a 43% gross margin. </li>
</ul>


Aptamer Group 0.33p £6.57m (APTA.L) The developer of novel Optimer binders to enable innovation in the life sciences industry yesterday reported Interims to December 2024.
Its revenue improved to £0.7m from £0.3m with an EBITDA loss of £1.1m down from £1.8m, while net cash is £2m after raising funds last year at 0.2p.
The strategy is to create value through the development of high-value Optimer assets with licensing potential through commercial partners, while generating revenues from fee-for-service work, which has a 43% gross margin. 


10X Genomics Inc-Class A - Hybridan Small Cap Feast: 12/03/2025

United Kingdom

Intercede is a cybersecurity software company specializing in digital identities, credential management, and secure mobility solutions. It provides a suite of products, including MyID, for organizations to create, issue, and manage trusted digital identities and replace insecure passwords with strong authentication. The company was founded in 1992 and is headquartered in Lutterworth, United Kingdom.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Intercede (IGP LN)

Quartix Holdings plc - Hybridan Small Cap Feast: 03/07/2025

The Company reports the IPO has received strong investor interest and based on firm orders received to date, the institutional offer is heavily...

Hybridan

Hybridan Small Cap Feast: 01/05/2025

The Company still plans to seek admission of the Company's entire issued and to be issued share capital to trading on AIM concurrent with the...

Hybridan

Surface Transforms PLC - Duplicate of Hybridan Small Cap Feast: 02/04/2025

The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m.

Hybridan

10X Genomics Inc-Class A - Hybridan Small Cap Feast: 12/03/2025

Aptamer Group 0.33p £6.57m (APTA.L) The developer of novel Optimer binders to enable innovation in the life sciences industry yesterday reported...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)